Public debate : the US food and drug administration and new drug approvals ; a safety vs. innovation paradox?
Year of publication: |
2013
|
---|---|
Authors: | Hemphill, Thomas A. |
Published in: |
Innovation: organization & management : IOM. - Abingdon, Oxon : Taylor & Francis, ISSN 1447-9338, ZDB-ID 2176456-6. - Vol. 15.2013, 3, p. 364-367
|
Subject: | pharmatheutical research and development | pharmaceutical industry business model | repurposing pharmaceuticals: safety first | US food and drug administration | USA | United States | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Arzneimittelrecht | Pharmaceutical law | Innovation | Pharmakologie | Pharmacology | Lebensmittelsicherheit | Food safety | Industrieforschung | Industrial research | Arzneimittelmarkt | Pharmaceutical market |
-
Michaeli, Daniel, (2024)
-
Product safety spillovers and market viability for biologic drugs
Romley, John, (2017)
-
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona, (2017)
- More ...
-
Hemphill, Thomas A., (2020)
-
Generic drug competition: The pharmaceutical industry “gaming” controversy
Hemphill, Thomas A., (2019)
-
White III, George O., (2020)
- More ...